O	0	9	Nutrition
O	10	18	Literacy
O	19	24	among
O	25	31	Cancer
O	32	41	Survivors
O	41	42	:
O	43	54	Feasibility
O	55	62	Results
O	63	67	from
O	68	71	the
O	72	79	Healthy
O	80	86	Eating
O	87	90	and
O	91	97	Living
O	98	105	Against
O	106	112	Breast
O	113	119	Cancer
O	120	121	(
O	121	125	HEAL
O	125	126	-
O	126	129	BCa
O	129	130	)
O	131	136	Study
O	136	137	:
O	138	139	a
O	140	145	Pilot
O	146	156	Randomized
O	157	167	Controlled
O	168	173	Trial
O	173	174	.

O	175	184	Knowledge
O	185	187	of
O	188	197	nutrition
O	198	203	among
O	204	210	breast
O	211	217	cancer
O	218	226	patients
O	227	229	is
O	230	242	insufficient
O	242	243	,
O	244	251	despite
O	252	257	their
O	258	268	motivation
O	269	271	to
O	272	276	seek
O	277	282	valid
O	283	294	information
O	295	300	about
O	301	308	healthy
O	309	313	food
O	314	321	choices
O	321	322	.

O	323	327	This
O	328	333	study
O	334	342	examines
O	343	346	the
O	347	358	feasibility
O	359	361	of
B-intervention	362	371	nutrition
I-intervention	372	381	education
O	382	391	workshops
O	392	395	for
O	396	402	cancer
O	403	412	survivors
O	412	413	,
O	414	416	to
O	417	423	inform
O	424	427	the
O	428	434	design
O	435	437	of
O	438	439	a
O	440	445	multi
O	445	446	-
O	446	452	center
O	453	465	intervention
O	465	466	.

B-total-participants	467	472	Fifty
I-total-participants	472	473	-
I-total-participants	473	477	nine
B-eligibility	478	484	female
I-eligibility	485	492	English
I-eligibility	492	493	-
I-eligibility	493	501	speaking
I-eligibility	502	508	breast
I-eligibility	509	515	cancer
I-eligibility	516	524	patients
I-eligibility	524	525	,
I-eligibility	526	529	who
I-eligibility	530	533	had
I-eligibility	534	543	completed
I-eligibility	544	553	treatment
O	553	554	,
O	555	559	were
O	560	568	enrolled
O	568	569	.

O	570	582	Participants
O	583	587	were
O	588	598	randomized
O	599	601	to
O	602	605	the
O	606	618	intervention
O	619	621	or
B-control	622	629	control
I-control	630	635	group
O	635	636	.

O	637	640	The
O	641	653	intervention
O	654	659	group
O	660	668	attended
O	669	672	six
O	673	682	nutrition
O	683	692	education
O	693	701	sessions
O	701	702	,
O	703	706	and
O	707	710	the
O	711	718	control
O	719	724	group
O	725	733	received
O	734	743	brochures
O	743	744	.

O	745	757	Measurements
O	758	762	were
O	763	767	done
O	768	770	at
O	771	779	baseline
O	780	783	and
O	784	785	3
O	785	786	-
O	786	791	month
O	792	798	follow
O	798	799	-
O	799	801	up
O	802	805	and
O	806	814	included
O	815	818	the
O	819	829	Assessment
O	830	840	Instrument
O	841	844	for
O	845	851	Breast
O	852	858	Cancer
O	859	860	(
O	860	864	NLit
O	864	865	-
O	865	868	BCa
O	868	869	)
O	869	870	,
O	871	876	fruit
O	876	877	/
O	877	886	vegetable
O	887	890	and
O	891	898	general
O	899	905	health
O	906	914	literacy
O	915	924	screeners
O	924	925	.

O	926	932	Height
O	933	936	and
O	937	943	weight
O	944	948	were
O	949	957	measured
O	957	958	.

O	959	966	Changes
O	967	969	in
O	970	979	nutrition
O	980	988	literacy
O	988	989	,
O	990	996	health
O	997	1005	literacy
O	1005	1006	,
O	1007	1010	and
O	1011	1015	food
O	1016	1022	intake
O	1023	1027	from
O	1028	1036	baseline
O	1037	1039	to
O	1040	1046	follow
O	1046	1047	-
O	1047	1049	up
O	1050	1051	(
O	1051	1057	within
O	1057	1058	-
O	1058	1063	group
O	1064	1070	change
O	1070	1071	)
O	1072	1076	were
O	1077	1087	calculated
O	1088	1091	for
O	1092	1096	both
O	1097	1103	groups
O	1104	1105	(
O	1105	1111	effect
O	1112	1117	sizes
O	1118	1122	were
O	1123	1131	reported
O	1132	1134	as
O	1135	1140	Cohen
O	1140	1141	'
O	1141	1142	s
O	1143	1144	d
O	1144	1145	)
O	1145	1146	.

O	1147	1159	Participants
O	1160	1164	were
O	1165	1171	mostly
B-ethinicity	1172	1177	white
O	1177	1178	,
O	1179	1183	with
O	1184	1185	a
O	1186	1190	mean
O	1191	1194	age
O	1195	1197	of
B-age	1198	1200	58
I-age	1201	1206	years
O	1206	1207	,
O	1208	1211	BMI
O	1212	1214	of
O	1215	1217	31
O	1217	1218	.
O	1218	1219	6
O	1220	1222	kg
O	1222	1223	/
O	1223	1225	m2
O	1225	1226	,
O	1227	1230	and
O	1231	1234	had
O	1235	1242	college
O	1243	1250	degrees
O	1250	1251	.

B-outcome	1252	1258	Follow
I-outcome	1258	1259	-
I-outcome	1259	1261	up
I-outcome	1262	1267	rates
O	1268	1272	were
O	1273	1277	high
O	1278	1279	(
B-cv-bin-percent	1279	1281	89
I-cv-bin-percent	1281	1282	%
O	1283	1284	=
O	1285	1292	control
O	1293	1296	and
B-iv-bin-percent	1297	1299	77
I-iv-bin-percent	1299	1300	%
O	1301	1302	=
O	1303	1315	intervention
O	1316	1321	group
O	1321	1322	)
O	1322	1323	.

O	1324	1326	At
O	1327	1335	baseline
O	1335	1336	,
O	1337	1349	participants
O	1350	1356	scored
O	1357	1361	high
O	1362	1365	for
O	1366	1370	most
B-outcome	1371	1375	NLit
I-outcome	1375	1376	-
I-outcome	1376	1379	BCa
I-outcome	1380	1390	assessment
I-outcome	1391	1401	components
O	1402	1408	except
O	1409	1413	food
O	1414	1422	portions
O	1423	1425	in
O	1426	1430	both
O	1431	1437	groups
O	1437	1438	.

O	1439	1441	At
O	1442	1445	the
O	1446	1447	3
O	1447	1448	-
O	1448	1453	month
O	1454	1460	follow
O	1460	1461	-
O	1461	1463	up
O	1463	1464	,
B-outcome	1465	1471	effect
I-outcome	1472	1477	sizes
I-outcome	1478	1479	(
I-outcome	1479	1480	d
I-outcome	1480	1481	)
I-outcome	1482	1484	on
I-outcome	1485	1488	the
I-outcome	1489	1493	NLit
I-outcome	1493	1494	-
I-outcome	1494	1497	BCa
O	1498	1504	ranged
O	1505	1509	from
O	1510	1511	-
O	1511	1512	0
O	1512	1513	.
O	1513	1514	5
O	1515	1517	to
O	1518	1519	0
O	1519	1520	.
O	1520	1522	16
O	1522	1523	.

O	1524	1527	The
O	1528	1533	study
O	1534	1537	met
O	1538	1541	its
O	1542	1553	recruitment
O	1554	1559	goals
O	1560	1566	within
O	1567	1568	6
O	1569	1575	months
O	1575	1576	.

O	1577	1582	Focus
O	1583	1589	groups
O	1590	1599	indicated
O	1600	1604	that
O	1605	1606	(
O	1606	1607	a
O	1607	1608	)
O	1609	1618	attending
O	1619	1622	six
O	1623	1631	sessions
O	1632	1635	was
O	1636	1646	acceptable
O	1646	1647	,
O	1648	1649	(
O	1649	1650	b
O	1650	1651	)
O	1652	1660	patients
O	1661	1666	found
O	1667	1673	social
O	1673	1674	/
O	1674	1683	emotional
O	1684	1691	support
O	1691	1692	,
O	1693	1694	(
O	1694	1695	c
O	1695	1696	)
O	1697	1709	improvements
O	1710	1716	should
O	1717	1724	include
O	1725	1736	information
O	1737	1740	for
O	1741	1748	special
O	1749	1754	diets
O	1755	1758	and
O	1759	1766	booster
O	1767	1775	sessions
O	1775	1776	.

O	1777	1781	This
O	1782	1787	pilot
O	1788	1793	study
O	1794	1802	suggests
O	1803	1807	that
O	1808	1811	the
O	1812	1824	intervention
O	1825	1828	was
O	1829	1839	acceptable
O	1840	1843	and
O	1844	1848	that
O	1849	1856	scaling
O	1857	1859	up
O	1860	1862	of
O	1863	1867	this
O	1868	1880	intervention
O	1881	1883	is
O	1884	1892	feasible
O	1893	1896	and
O	1897	1902	could
O	1903	1910	provide
O	1911	1918	benefit
O	1919	1921	to
O	1922	1928	breast
O	1929	1935	cancer
O	1936	1945	survivors
O	1945	1946	.
